A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects with Moderately to Severely Active Crohn’s Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy

Project: Research

Project Details

Effective start/end date8/10/217/10/26


  • Crohn’s Disease
  • treatment safety
  • treatment efficacy
  • phase 3 study